Genflow Biosciences plc (LON:GENF – Get Free Report) was up 2.4% on Friday . The stock traded as high as GBX 2.10 and last traded at GBX 2.10. Approximately 139,341 shares changed hands during trading, a decline of 95% from the average daily volume of 2,580,581 shares. The stock had previously closed at GBX 2.05.
Genflow Biosciences Price Performance
The firm has a fifty day simple moving average of GBX 2.18 and a two-hundred day simple moving average of GBX 1.99. The firm has a market capitalization of £11.25 million, a P/E ratio of -6.33 and a beta of 2.11.
Genflow Biosciences (LON:GENF – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported GBX (0.33) earnings per share for the quarter. Genflow Biosciences had a net margin of 840.76% and a return on equity of 377.33%.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Stories
- Five stocks we like better than Genflow Biosciences
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
